Many studies have confirmed the existence of AKT activation in critical cancers affecting human survival, such as non-small cell lung cancer (NSCLC), gastric cancer, and head and neck cancer, and laryngeal cancer is no exception20–24. This evidence concerns the gene AKT1 and head and neck cancer.